Skip to Main Content

Paper Details

A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations.
Cancer Cell
385
2017
AKT, Cancer, IDH1, PI3K, PTEN, RNA, STK11, VHL, VHL mutations, cancers, downstream transcriptional targets, human, mTOR, mutated genes, mutation hotspot residues
Author NameAffiliation
Yiqun ZhangDan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine
Patrick Kwok-Shing NgUniversity of Texas MD Anderson Cancer Center, USA Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center
Yuexin LiuThe University of Texas MD Anderson Cancer Center
Yuexin LiuThe University of Texas MD Anderson Cancer Center
Rehan AkbaniThe University of Texas MD Anderson Cancer Center
Rehan AkbaniThe University of Texas MD Anderson Cancer Center
Angela HadjipanayisHarvard Medical School, Brigham and Women's Hospital
Angela HadjipanayisHarvard Medical School, Brigham and Women's Hospital
Angeliki PantaziHarvard Medical School, USA KEW Inc.
Angeliki PantaziHarvard Medical School, USA KEW Inc.
Christopher A BristowInstitute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center
Christopher A BristowInstitute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center
Harshad S MahadeshwarInstitute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center
Harshad S MahadeshwarInstitute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center
Jiabin TangInstitute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center
Jiabin TangInstitute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center
Jianhua ZhangInstitute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center
Jianhua ZhangInstitute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center
Lixing YangCenter for Biomedical Informatics, Harvard Medical School
Lixing YangCenter for Biomedical Informatics, Harvard Medical School
Sahil SethInstitute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center
Sahil SethInstitute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center
Semin LeeCenter for Biomedical Informatics, Harvard Medical School
Semin LeeCenter for Biomedical Informatics, Harvard Medical School
Xiaojia RenHarvard Medical School, USA KEW Inc.
Xiaojia RenHarvard Medical School, USA KEW Inc.
Xingzhi SongInstitute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center
Xingzhi SongInstitute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center
Huandong SunInstitute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center
Jonathan G SeidmanHarvard Medical School
Jonathan G SeidmanHarvard Medical School
Lovelace J LuquetteCenter for Biomedical Informatics, Harvard Medical School
Ruibin XiCenter for Biomedical Informatics, Harvard Medical School
Lynda ChinInstitute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, USA The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology, Harvard University Cambridge
Lynda ChinInstitute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, USA The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology, Harvard University Cambridge
Alexei ProtopopovInstitute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, USA KEW Inc.
Alexei ProtopopovInstitute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, USA KEW Inc.
Toni K ChoueiriDana-Farber Cancer Institute
Carter Van WaesNational Institute on Deafness and Other Communication Disorders, National Institutes of Health
Carter Van WaesNational Institute on Deafness and Other Communication Disorders, National Institutes of Health
John N WeinsteinThe University of Texas MD Anderson Cancer Center
John N WeinsteinThe University of Texas MD Anderson Cancer Center
Han LiangThe University of Texas MD Anderson Cancer Center, University of Texas MD Anderson Cancer Center
Peter J ParkCenter for Biomedical Informatics, Harvard Medical School, Brigham and Women's Hospital
Peter J ParkCenter for Biomedical Informatics, Harvard Medical School, Brigham and Women's Hospital
Raju KucherlapatiHarvard Medical School, Brigham and Women's Hospital
Raju KucherlapatiHarvard Medical School, Brigham and Women's Hospital
Gordon B MillsUniversity of Texas MD Anderson Cancer Center
Gordon B MillsUniversity of Texas MD Anderson Cancer Center
Chad J CreightonDan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, The University of Texas MD Anderson Cancer Center
  • 1 - 50

Datasets